A Study to Evaluate the Mass Balance, Pharmacokinetics (PK), Metabolism and Excretion of TAK-954 Containing Microtracer ([14C]-TAK-954) in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2018

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

[14C]-TAK-954

\[14C\]-TAK-954 intravenous infusion.

Trial Locations (1)

PRAHS, Groningen